Skip to main content
. 2017 Nov 8;2(12):1385–1391. doi: 10.1001/jamacardio.2017.3944

Figure 1. Efficacy Outcomes Stratified by Baseline Low-Density Lipoprotein Cholesterol (LDL-C) Levels and Intensity of Background Statin Treatment.

Figure 1.

Hazard ratios (HRs) and 95% CIs are shown for the primary (composite of cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina, and coronary revascularization) and the key secondary (composite of cardiovascular death, myocardial infarction, and stroke) efficacy composite endpoints in the total population and (A) in patients with baseline LDL-C levels of less than 70 mg/dL vs those with LDL-C levels of at least 70 mg/dL and (B) in patients treated with maximal (atorvastatin calcium, 80 mg/d, or rosuvastatin, 40 mg/d) and submaximal background statin therapy.